Mydecine Innovations Group
09/01/2021
Mydecine COO Damon Michaels is back on The Dales Report!
In this episode, Michaels shares our exciting five-year partnership with Johns Hopkins University, reflects on how fast the industry has progressed in the last 12 months, our advancements with our lead drug candidates MYCO-001 AND MYCO-004, and our goals to expand the treatment options for those that need it.
COO Damon Michaels On Mydecine’s Collaboration With Johns Hopkins University - PT 2 In our first interview with Mydecine Innovations Group (NEO: MYCO)(OTCMKTS: MYCOF) we talked about the five-year agreement with the Johns Hopkins University ...
Did you know there are over 100 different types of soil in Jamaica?
Mydecine COO, Damon Michaels sits down with The Dales Report to discuss the benefits of having Jamaica as a base for our mushroom cultivation, not only in terms of legality but in the fertility of Jamaican soil which contributes to the variety of genetic species.
08/11/2021
We are excited to announce that we have commissioned a local Denver female artist to join us at the Telluride Mushroom Festival next week to capture this event. will be live painting at the Mydecine tent, and participants will have the opportunity to enter our raffle for a chance to win this original piece of artwork!
Mydecine is the main presenting sponsor of the 2021 Telluride Mushroom Festival, August 18th thru 22nd, a community gathering to celebrate all things fungi. Attendees will hear from experts on the latest advancements in mycology, chemistry and clinical use of psychedelic mushrooms. Be sure to stay tuned for further details on special guest performances and more! 🍄
👉 www.tellurideinstitute.org/telluride-mushroom-festival/
08/10/2021
Join us today at 3PM EDT for BTIG’s , featuring the “Reemergence and Development of Psychedelics in Mental Health Conditions” with hosts Josh Bartch and Rob Roscow.
Learn more here 👉https://fal.cn/3hjFK
We look forward to seeing you online soon!
08/09/2021
It’s almost time for BTIG’s Biotechnology Conference! We’re excited to announce that Mydecine CEO Josh Bartch and CSO Robert Roscow be hosting a fireside chat will speak tomorrow, August 10th at 3PM EDT. Don’t forget to partake.
Mydecine to Participate in Upcoming Investor Events in August 2021 DENVER, July 28, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging...
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
Denver, CO
